Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Capital Expenditures (2020 - 2023)

Historic Capital Expenditures for Cullinan Therapeutics (CGEM) over the last 3 years, with Q2 2023 value amounting to $49000.0.

  • Cullinan Therapeutics' Capital Expenditures changed N/A to $49000.0 in Q2 2023 from the same period last year, while for Dec 2023 it was $208000.0, marking a year-over-year decrease of 8164.17%. This contributed to the annual value of $208000.0 for FY2023, which is 8164.17% down from last year.
  • Cullinan Therapeutics' Capital Expenditures amounted to $49000.0 in Q2 2023.
  • Over the past 5 years, Cullinan Therapeutics' Capital Expenditures peaked at $882000.0 during Q4 2022, and registered a low of -$1000.0 during Q4 2020.
  • Over the past 3 years, Cullinan Therapeutics' median Capital Expenditures value was $26500.0 (recorded in 2020), while the average stood at $168875.0.